Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - CAPITAL EXPENDITURES
Capital Expenditures FATE - Fate Therapeutics, Inc.
-6.15 M
LAST VALUE
65.16%
2 YEAR CAGR
-21.72%
5 YEAR CAGR
-38.09%
10 YEAR CAGR